Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: New management and cash for Verditek and Image Scan orders decline

AIM movers: itim gains multi-million pound contract and United Oil and Gas raises cash for Jamaica

AIM movers: Hornby continues to rise while Base Resources slumps

Tristel doubles dividend

AIM reversal: Location Sciences still has to prove that profitability is Sorted

Director deals: Sylvania Platinum chair nearly doubles stake

Aquis weekly movers: All Things Considered raises growth capital

AIM weekly movers: Marlowe soars following disposal plan

AIM movers: Frasers Group buys Hornby stake and litigation for Active Energy

AIM movers: Australian deal for Powerhouse Energy and ex-dividends

Why companies left AIM in January 2024

H&T acquires small business finance expertise

AIM movers: Zinnwald Lithium increases resource and Shield Diagnostics prescription numbers revised downwards

Tip update: Lok’nStore continues progress

AIM movers: Engage XR contract wins and Nightcap buys Piano Works funded by subscription at a premium

Tip update: Transense Technologies short-term expectations reduced to fund long-term profit

AIM movers: Spaceandpeople pleases and Petards gains continue

Director deals: Is the FRP Advisory chair worth following?

AIM weekly movers: Further rise for Renalytix

Aquis weekly movers: Coinsilium investee company gets global bank investment

AIM movers: Fiske profit jump and Baron Oil’s discounted fundraising

Jarvis Securities restarts dividend and ex-dividends

Bloomsbury Publishing’s fantasy upgrade

AIM movers: Potential Costa Rica project for ATOME and Vast Resources capital reorganisation

Retail offer by JPMorgan Global Growth & Income

Ultimate Products considering buy backs with surplus cash

AIM movers: Renalytix share price soaring and Saietta still needs cash

Did Naked Wines retain the wrong business?

Tip update: Nanoco preparing for cash distribution

Renalytix share price jumps after New York opens

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020